Clinical Trial Update: Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children [Phase 2, Phase 3]

View source ↗

Summary

This document is an update on a Phase 2/Phase 3 therapy optimization trial for relapsed or refractory pediatric brain tumors, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Ependymoma
• Medulloblastoma
• Primitive Neuroectodermal Tumor

Snippet

Sponsor: University Hospital, Bonn | Conditions: Recurrent Brain Tumors, Supratentorial PNETs | Phase 2, Phase 3 | Status: COMPLETED